Hematology TimesNICE rejects DLBCL indication for CAR T-cell therapySeptember 20, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesGuidelines for proton therapy in mediastinal lymphomasSeptember 19, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesRisks of watchful waiting in follicular lymphomaSeptember 19, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesFDA approves drug for hairy cell leukemiaSeptember 14, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesMRD data added to venetoclax labelSeptember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesRegimens produce similar results in FLSeptember 7, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesIbrutinib maintains efficacy over timeSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTYK2 inhibitors could treat ALCL, team saysSeptember 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesPredicting early outcomes in DLBCLAugust 30, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesNICE says CAR T-cell therapy isn’t cost-effectiveAugust 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for DLBCL, PMBCLAugust 28, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for ALL, DLBCLAugust 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesFDA approves new use for ibrutinib in WMAugust 27, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCombo produces high response rate in CLLAugust 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesSignal strength tied to potency of CAR T-cell therapyAugust 22, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
